FANTACUZZI, MARIALUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 3.810
EU - Europa 3.019
AS - Asia 2.555
SA - Sud America 269
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 9.689
Nazione #
US - Stati Uniti d'America 3.704
SG - Singapore 921
CN - Cina 805
IT - Italia 773
IE - Irlanda 413
TR - Turchia 378
UA - Ucraina 350
SE - Svezia 347
FR - Francia 250
BR - Brasile 241
GB - Regno Unito 237
IN - India 215
DE - Germania 190
PL - Polonia 124
VN - Vietnam 103
FI - Finlandia 101
CA - Canada 74
RU - Federazione Russa 59
ES - Italia 33
AT - Austria 32
CZ - Repubblica Ceca 24
NL - Olanda 23
MX - Messico 22
BE - Belgio 21
HK - Hong Kong 21
JP - Giappone 20
BD - Bangladesh 16
ZA - Sudafrica 16
LT - Lituania 14
PT - Portogallo 12
KR - Corea 10
AR - Argentina 9
ID - Indonesia 8
IQ - Iraq 8
PH - Filippine 7
PK - Pakistan 6
DZ - Algeria 5
HR - Croazia 5
TW - Taiwan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
GR - Grecia 4
PE - Perù 4
SA - Arabia Saudita 4
EC - Ecuador 3
IR - Iran 3
YE - Yemen 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
MY - Malesia 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 9.689
Città #
Singapore 678
Chandler 501
Jacksonville 429
Dublin 407
Ashburn 273
Dallas 248
Izmir 244
Dearborn 210
Chieti 209
Beijing 203
Princeton 169
Southend 148
Nanjing 128
The Dalles 116
Los Angeles 109
Kraków 89
Santa Clara 89
Cambridge 82
Ann Arbor 79
Wilmington 69
Nanchang 63
New York 62
Munich 55
Altamura 49
Tongling 48
Ho Chi Minh City 37
Buffalo 36
Boardman 33
Warsaw 33
Pescara 32
Hebei 31
Bosa 30
Shenyang 30
São Paulo 30
Teramo 30
Redondo Beach 27
Helsinki 26
Jiaxing 25
Brno 23
Jinan 23
Denver 22
Kunming 22
Washington 22
Brooklyn 21
Brussels 21
Vienna 21
Ottawa 20
Stockholm 20
Tianjin 20
Atlanta 19
Changsha 19
Rome 19
Toronto 19
Chennai 18
Hong Kong 18
London 18
Milan 18
Kocaeli 17
Hefei 16
Tokyo 15
Amsterdam 14
Hanoi 14
Houston 14
Turku 14
Johannesburg 13
Montreal 13
Poplar 13
Woodbridge 13
Chicago 11
Hangzhou 11
Nuremberg 11
Orem 11
Manchester 10
Norwalk 10
San Francisco 10
Augusta 9
Falls Church 9
Mexico City 9
Ningbo 9
Ankara 8
Dong Ket 8
Porto 8
Redwood City 8
Seattle 8
Zhengzhou 8
Belo Horizonte 7
Biên Hòa 7
Changchun 7
Como 7
Guangzhou 7
Nogarole Vicentino 7
Phoenix 7
San Mateo 7
San Vito Chietino 7
Bari 6
Bologna 6
Brasília 6
Haiphong 6
Moscow 6
Niederkirchen bei Deidesheim 6
Totale 5.953
Nome #
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 173
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 168
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 166
Anticancer Activity of Stilbene-Based Derivatives 155
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 152
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 150
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 148
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 148
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 147
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 146
Recent developments of amidine-like compounds as selective NOS inhibitors 138
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 138
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 136
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 135
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 135
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 135
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 135
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 131
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 131
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 130
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 129
null 128
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 128
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 127
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 126
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 126
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 124
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 122
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 122
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 120
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 120
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 120
Enantiomeric separation of some demethylated analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 117
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 117
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 115
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 114
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 111
Amidine-Based Compounds Affecting L-Arginine Metabolism 111
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 111
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 111
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 111
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 110
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 109
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 108
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 108
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 108
Structural development studies of PPARs ligands based on tyrosine scaffold 107
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 105
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 105
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 103
Enantioseparazione di analoghi chirali dei fibrati in Elettroforesi Capillare e nano-Cromatografia Liquida 103
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 103
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 101
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 100
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 99
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 97
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 96
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 93
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 92
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 92
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 92
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 91
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 90
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 90
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 89
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 89
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 88
Methods to Evaluate the Activity of Nitric Oxide Synthase 87
PPAR Ligands Containing Stilbene Scaffold 87
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 87
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 86
Separazione enantiomerica di analoghi chirali dell'acido clofibrico mediante elettroforesi capillare 86
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 86
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 85
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 85
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 82
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 81
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 80
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 80
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 80
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 78
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 77
N-Acylsulfonylamides as a new class of PPARa antagonists 76
Enantiomeric separation of some chiral analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 73
Development of CDK4/6 Inhibitors: A Five Years Update 69
Antiviral Peptides as Anti-Influenza Agents 69
Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery 65
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 64
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection 64
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer 61
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 59
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 58
Pegylation approach applied to erlotinib–carbonic anhydrase inhibitors hybrids towards anticancer agents 56
New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study 47
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy 47
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 46
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 43
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 40
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 39
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 30
Totale 10.228
Categoria #
all - tutte 39.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 110 14 44 90 72 11 39
2021/2022609 10 11 22 95 54 22 23 52 97 20 70 133
2022/20231.441 103 202 108 136 133 305 71 110 178 17 52 26
2023/2024693 51 21 61 14 43 216 166 10 4 30 9 68
2024/20251.645 73 303 268 21 38 90 64 96 161 73 237 221
2025/20261.916 309 129 444 514 478 42 0 0 0 0 0 0
Totale 10.256